In vivo performance evaluation of a transdermal near- infrared fluorescence resonance energy transfer affinity sensor for continuous glucose monitoring.
暂无分享,去创建一个
Ashok Gowda | Ralph Ballerstadt | Colton Evans | R. McNichols | R. Ballerstadt | C. Evans | A. Gowda | Roger McNichols
[1] A. Turner,et al. Ferrocene-mediated enzyme electrode for amperometric determination of glucose. , 1984, Analytical chemistry.
[2] Michael M. Engelgau,et al. Type 2 diabetes among North adolescents: An epidemiologic health perspective , 2000 .
[3] Igor K Lednev,et al. Photonic crystal carbohydrate sensors: low ionic strength sugar sensing. , 2003, Journal of the American Chemical Society.
[4] G. Edelman,et al. Concanavalin A derivatives with altered biological activities. , 1973, Proceedings of the National Academy of Sciences of the United States of America.
[5] H. Dautzenberg,et al. Viscosimetric affinity assay. , 1996, Analytical biochemistry.
[6] O. Rolinski,et al. Near-infrared fluorescence lifetime assay for serum glucose based on allophycocyanin-labeled concanavalin A. , 2001, Analytical biochemistry.
[7] M. Shults,et al. A subcutaneous glucose sensor with improved longevity, dynamic range, and stability of calibration. , 2000, Diabetes care.
[8] Y. Ito,et al. Interferon induction in mouse spleen cells by mitogenic and nonmitogenic lectins. , 1984, Journal of immunology.
[9] Michael J. McShane,et al. Variable Selection in Multivariate Calibration of a Spectroscopic Glucose Sensor , 1997 .
[10] L. S. Kind,et al. Concanavalin A in vivo: Induction of Hemorrhagic Skin Lesions (Arthus-Like Reactions) in Mice , 1968, Science.
[11] U. Haueter,et al. Clinical performance of a continuous viscometric affinity sensor for glucose. , 2004, Diabetes technology & therapeutics.
[12] E. O’Neill,et al. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6 , 1994, The Journal of experimental medicine.
[13] J. Schultz,et al. A fluorescence affinity hollow fiber sensor for continuous transdermal glucose monitoring. , 2000, Analytical chemistry.
[14] Kaiming Ye,et al. Genetic engineering of an allosterically based glucose indicator protein for continuous glucose monitoring by fluorescence resonance energy transfer. , 2003, Analytical chemistry.
[15] Michael J. McShane,et al. Glucose-Sensitive Nanoassemblies Comprising Affinity-Binding Complexes Trapped in Fuzzy Microshells , 2004, Journal of Fluorescence.
[16] M. Leist,et al. A novel mechanism of murine hepatocyte death inducible by concanavalin A. , 1996, Journal of hepatology.
[17] A. Wendel,et al. Concanavalin A hepatotoxicity in mice: Tumor necrosis factor–mediated organ failure independent of caspase‐3–like protease activation , 1999, Hepatology.
[18] H. Heise,et al. Noninvasive Blood Glucose Assay by Near-Infrared Diffuse Reflectance Spectroscopy of the Human Inner Lip , 1993 .
[19] A. Wendel,et al. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. , 1992, The Journal of clinical investigation.
[20] S. Daunert,et al. Fluorescence Glucose Detection: Advances Toward the Ideal In Vivo Biosensor , 2004, Journal of Fluorescence.
[21] Th. Förster. Zwischenmolekulare Energiewanderung und Fluoreszenz , 1948 .
[22] L. Lanier,et al. Lectin-dependent and anti-CD3 induced cytotoxicity are preferentially mediated by peripheral blood cytotoxic T lymphocytes expressing Leu-7 antigen. , 1986, Journal of immunology.
[23] M A Arnold,et al. Strategies for coupling digital filtering with partial least-squares regression: application to the determination of glucose in plasma by Fourier transform near-infrared spectroscopy. , 1993, Analytical chemistry.
[24] E. Möller,et al. CONTACT-INDUCED CYTOTOXICITY BY LYMPHOID CELLS CONTAINING FOREIGN ISOANTIGENS. , 1965, Science.
[25] D. S. Letbetter,et al. Surface-immobilized dextran limits cell adhesion and spreading. , 2000, Biomaterials.
[26] J. Tuomilehto,et al. Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. , 2000, Diabetes care.
[27] T von Woedtke,et al. Implantable Glucose Sensors: Comparison between in Vitro and in Vivo Kinetics , 1991, The International journal of artificial organs.
[28] S. Toyabe,et al. Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice. , 1997, Journal of immunology.
[29] P. Vonk,et al. Microdialysis of Glucose in Subcutaneous Adipose Tissue up to 3 Weeks in Healthy Volunteers , 1998, Diabetes Care.
[30] J. Schultz,et al. Affinity Sensor: A New Technique for Developing Implantable Sensors for Glucose and Other Metabolites , 1982, Diabetes Care.
[31] J. Pickup,et al. Developing glucose sensors for in vivo use. , 1993, Trends in biotechnology.
[32] Binghe Wang,et al. Progress in Boronic Acid-Based Fluorescent Glucose Sensors , 2004, Journal of Fluorescence.
[33] G. Edelman,et al. Activation of B lymphocytes by locally concentrated concanavalin A , 1972, European journal of immunology.
[34] Jerome S. Schultz,et al. Competitive-binding assay method based on fluorescence quenching of ligands held in close proximity by a multivalent receptor , 1997 .
[35] S. Massia,et al. Immobilized RGD peptides on surface-grafted dextran promote biospecific cell attachment. , 2001, Journal of biomedical materials research.
[36] M. Manns,et al. Concanavalin A-induced liver cell damage: activation of intracellular pathways triggered by tumor necrosis factor in mice. , 1998, Gastroenterology.
[37] Joseph R. Lakowicz,et al. Optical assay for glucose based on the luminescnence decay time of the long wavelength dye Cy5™. , 1997, Sensors and actuators. B, Chemical.
[38] G L Coté,et al. A fluorescence-based glucose biosensor using concanavalin A and dextran encapsulated in a poly(ethylene glycol) hydrogel. , 1999, Analytical chemistry.
[39] E. V. Thomas,et al. Noninvasive glucose monitoring in diabetic patients: a preliminary evaluation. , 1992, Clinical chemistry.
[40] S. Garg,et al. Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes. , 2004, Diabetes care.
[41] Ashok Gowda,et al. Fluorescence resonance energy transfer-based near-infrared fluorescence sensor for glucose monitoring. , 2004, Diabetes technology & therapeutics.
[42] Sohrab Mansouri,et al. A Miniature Optical Glucose Sensor Based on Affinity Binding , 1984, Bio/Technology.
[43] Peter G Jacobs,et al. Feasibility of continuous long-term glucose monitoring from a subcutaneous glucose sensor in humans. , 2004, Diabetes technology & therapeutics.
[44] W Kenneth Ward,et al. Vascularizing the tissue surrounding a model biosensor: how localized is the effect of a subcutaneous infusion of vascular endothelial growth factor (VEGF)? , 2003, Biosensors & bioelectronics.
[45] D. J. Harrison,et al. Performance of subcutaneously implanted needle-type glucose sensors employing a novel trilayer coating. , 1993, Analytical chemistry.
[46] M. Tyan. In Vivo Toxicity of Concanavalin A 1 , 1974, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[47] P. Pereira,et al. Modulation of cytolytic T cell function by lectins. , 1985, Journal of immunology.
[48] D. Gough,et al. Application of Chronic Intravascular Blood Glucose Sensor in Dogs , 1990, Diabetes.
[49] F. Sternberg,et al. On line continuous monitoring of subcutaneous tissue glucose in men by combining portable glucosensor with microdialysis , 1992, Diabetologia.
[50] David L. Meadows,et al. Design, manufacture and characterization of an optical fiber glucose affinity sensor based on an homogeneous fluorescence energy transfer assay system , 1993 .
[51] J. Hall,et al. T cell mitogens and polyclonal B cell activators. , 1987, Methods in enzymology.
[52] J. DeSesso,et al. Lectin teratogenesis. II: Demonstration of increased binding of concanavalin A to limb buds of rabbit embryos during the teratogenically sensitive period. , 1989, Teratology.